Mar 17 – Mar 18, 2021
Andrew A. Dahl, CEO of ZIVO Bioscience, Inc., presented the Transformative Opportunities in Immune Therapeutics & Nutrition at Maxim Group’s Inaugural Emerging Growth Virtual Conference
